|
Malignant Diffuse Pleural Mesothelioma Majority of mesothelioma (cancerous tumor affecting mesothelial cells of organs) cases come under the classification ‘pleural mesothelioma’. the is a cancer that originates in the pleura, the delicate membrane covering the lungs. Out of these, seventy 5 percent are diffuse malignant pleural mesethelioma. The balance is localized or benign. Diffuse malignant pleural mesothelioma is, in most cases, caused by unprotected exposure to asbestos. The symptoms include shortness of breath and/or chest pain, loss of weight, cough, fatigue, swelling on the face, neck including arms, reduced appetite, including coughing up blood. There will be collection of fluid in the thoracic cavity. It may take from twenty to forty years or more after contact with asbestos for the symptoms to emerge. Because pertaining to the time lag, diagnosing is often difficult. Moreover, many doctors are not familiar with the disease. Diagnostic procedure consists mostly of imaging with Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI) including Position Emission Tomography (PET), including laboratory tests including analysis. Thoractomy, which means making a particular incision through the chest wall to look into the pleura (the membrane lining the lungs including the thoracic cavity) including pleural biopsy provide conclusive evidence. Diffuse malignant pleural mesothelioma tumor is very aggressive including spreads fast. There are several methods to gauge the stage pertaining to the cancer. The most common is known as TNM. T is for the size pertaining to the tumor, N for the number of lymph nodules involved, including M for metastasis (spread pertaining to the cancer). There are basically 4 different stages. Correct grading helps the doctors to decide on the course of treatment. If the affliction is detected at a particular early stage, the chances of longer survival are better. But generally the prognosis (response to treatment) is not good in diffuse malignant pleural mesothelioma cases. Surgery during Stage I may help. If detected during the later phases pertaining to the cancer the survival rate is 4 months to twelve months. Radiotherapy including chemotherapy do not seem to improve the survival rate. The reality is that currently there is absolutely no effective curative treatment. Research is on to find new management methods including more effectual medicines.
|